Table 1 Respondent characteristics
Characteristic | FY15 | FY16 | FY17 | FY18 | FY19 |
|---|---|---|---|---|---|
N (%) | N (%) | N (%) | N (%) | N (%) | |
Number of sites | 80 (62) | 105 (81) | 109 (84) | 88 (68) | 58 (45) |
(of 130 total) | |||||
HIT members | 68 (85) | 95 (90) | 100 (92) | 85 (97) | 56 (97) |
Years in VA | |||||
≤ 3 | 13 (16) | 23 (22) | 17 (16) | 12 (14) | 5 (9) |
4 to 9 | 25 (31) | 31 (30) | 41 (38) | 31 (35) | 19 (33) |
10 to 19 | 25 (31) | 38 (36) | 33 (30) | 29 (33) | 27 (47) |
≥ 20 | 17 (21) | 13 (12) | 19 (17) | 16 (18) | 7 (12) |
Specialty | |||||
GI/Hepatology | 33 (4) | 42 (40) | 40 (37) | 34 (39) | 32 (55) |
Infectious disease | 17 (21) | 21 (20) | 19 (17) | 14 (16) | 9 (16) |
Pharmacy | 13 (16) | 31 (30) | 40 (37) | 31 (35) | 14 (24) |
Primary Care | 8 (10) | 3 (3) | 5 (5) | 5 (6) | 0 (0) |
Other | 9 (11) | 8 (8) | 5 (5) | 4 (5) | 3 (12) |
Degree | |||||
PharmD | 35 (44) | 35 (33) | 47 (43) | 33 (38) | 15 (26) |
NP | 13 (16) | 21 (20) | 24 (22) | 20 (23) | 18 (31) |
MD/PA | 16 (20) | 17 (16) | 23 (21) | 18 (20) | 13 (22) |
RN | 2 (3) | 8 (8) | 12 (11) | 14 (16) | 12 (21) |
Other | 14 (18) | 24 (23) | 3 (3) | 3 (3) | 0 (0) |
Site Complexity | |||||
1a (most complex) | 27 (33) | 34 (32) | 34 (31) | 30 (34) | 15 (26) |
1b | 14 (18) | 15 (14) | 17 (16) | 19 (22) | 10 (17) |
1c | 12 (15) | 16 (15) | 23 (21) | 14 (16) | 13 (22) |
2 | 14 (18) | 19 (18) | 14 (13) | 12 (14) | 8 (14) |
3 (least complex) | 12 (15) | 21 (20) | 21 (19) | 13 (15) | 12 (21) |